We appreciate the response from Lee and colleagues[@bib1] detailing a case of hemodynamic collapse from acute pulmonary vasoconstriction after protamine infusion during an atrial tachycardia ablation. Protamine reactions occur in approximately 1% of ablations, which is less frequent than after cardiopulmonary bypass, during which larger doses of protamine are given.[@bib2] Nevertheless, pulmonary vasoconstriction is 1 of the 3 classified protamine reactions in addition to hypotension from rapid infusion and anaphylaxis.[@bib3]

The case by Lee and colleagues[@bib1] was characterized by electromechanical dissociation in the setting of severe right ventricular enlargement and severe right ventricular dysfunction but without pulmonary embolus. These findings differ from our case of anaphylaxis, in which the patient had elevated peak airway pressures consistent with bronchospasm, circulatory collapse, and an absence of significant right heart enlargement or dysfunction.[@bib4]

Both cases highlight that supportive care (inotropic support and mechanical circulatory support as needed) is critical acutely in a protamine reaction. Prevention consists of both limiting protamine dosing to 50 mg over 10 minutes based on protamine labeling and minimizing protamine in patients with higher risk features for a reaction, such as vasectomy, prior protamine exposure, and NPH insulin use, as well as patients without the reserve to tolerate sequalae from protamine reactions (right and left heart failure). Future trials of hemostasis techniques that allow reduced or no protamine infusion are needed, especially in the population of patients at increased risk of protamine reaction and subsequent poor outcomes.
